Cite
MLA Citation
Nawar Diar Bakerly et al.. “Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups.” Respiratory medicine, vol. 147, 2019, pp. 58–65. http://access.bl.uk/ark:/81055/vdc_100077207022.0x000026